14 Treatment with tyrosine kinase inhibitors make PBMCs from patients with chronic myeloid leukemia less susceptible to HIV-1 infection: control of CD4+ T cell activation to control HIV-1 replication
Mercedes Bermejo,
Juan Ambrosioni,
Guiomar Bautista,
Núria Climent,
Elena Mateos,
Cristina Rovira,
Rafael Duarte,
Francisco Cervantes,
Montserrat Plana,
José M. Miró,
José Alcamí,
Mayte Coiras
Affiliations
Mercedes Bermejo
Instituto de Salud Carlos III, Madrid, Spain
Juan Ambrosioni
Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain
Guiomar Bautista
Hospital Puerta de Hierro, Madrid, Spain
Núria Climent
Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain
Elena Mateos
Instituto de Salud Carlos III, Madrid, Spain
Cristina Rovira
Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain
Rafael Duarte
Hospital Puerta de Hierro, Madrid, Spain
Francisco Cervantes
Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain
Montserrat Plana
Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain
José M. Miró
Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain
